SinoMab BioScience Ltd Sustainability Reports
SinoMab BioScience Limited is a biopharmaceutical company engaged in the research, development, and manufacturing of therapeutics for immunological diseases. The company specializes primarily in monoclonal antibody-based biologics.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
LEI: 9845009B6CEEC4694006
FIGI: BBG003M66N53
8 reports from 2019 to 2025